Skip to content

Clinical trials

Phase 3 Hypertension, Pulmonary trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 3 Country / region: Austria Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20071
20081
20096
20102
20121
20141
20192
20211
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics7
Bayer4
Novartis Pharmaceuticals2
Actelion1
Eli Lilly and Company1
Gilead Sciences1
GlaxoSmithKline1
Idorsia Pharmaceuticals Ltd.1
Insmed Incorporated1
Liquidia Technologies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary21
Pulmonary Arterial Hypertension13
Cardiovascular Diseases2
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Hypertension2
Lung Diseases2
Lung Diseases, Interstitial2
Respiratory Tract Diseases2
Vascular Diseases2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.